The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In-vitro Diagnostic Services-Global Market Insights and Sales Trends 2024
Synopsis
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
The global In-vitro Diagnostic Services market size is expected to reach US$ 87000 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of In-vitro Diagnostic Services in various end use industries. The expanding demands from the Hospitals, Point-Of-Care Testing, Laboratories and Academic Institutes, are propelling In-vitro Diagnostic Services market. Infectious Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diabetes Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In-vitro Diagnostic Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In-vitro Diagnostic Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In-vitro Diagnostic Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In-vitro Diagnostic Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In-vitro Diagnostic Services covered in this report include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics and Siemens, etc.
The global In-vitro Diagnostic Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
Sysmex
Thermofisher
Global In-vitro Diagnostic Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In-vitro Diagnostic Services market, Segment by Type:
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Global In-vitro Diagnostic Services market, by Application
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In-vitro Diagnostic Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
The global In-vitro Diagnostic Services market size is expected to reach US$ 87000 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of In-vitro Diagnostic Services in various end use industries. The expanding demands from the Hospitals, Point-Of-Care Testing, Laboratories and Academic Institutes, are propelling In-vitro Diagnostic Services market. Infectious Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diabetes Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In-vitro Diagnostic Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In-vitro Diagnostic Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In-vitro Diagnostic Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In-vitro Diagnostic Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In-vitro Diagnostic Services covered in this report include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics and Siemens, etc.
The global In-vitro Diagnostic Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
Sysmex
Thermofisher
Global In-vitro Diagnostic Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In-vitro Diagnostic Services market, Segment by Type:
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Global In-vitro Diagnostic Services market, by Application
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In-vitro Diagnostic Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In-vitro Diagnostic Services
1.1 In-vitro Diagnostic Services Market Overview
1.1.1 In-vitro Diagnostic Services Product Scope
1.1.2 In-vitro Diagnostic Services Market Status and Outlook
1.2 Global In-vitro Diagnostic Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In-vitro Diagnostic Services Market Size by Region (2018-2029)
1.4 Global In-vitro Diagnostic Services Historic Market Size by Region (2018-2023)
1.5 Global In-vitro Diagnostic Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In-vitro Diagnostic Services Market Size (2018-2029)
1.6.1 North America In-vitro Diagnostic Services Market Size (2018-2029)
1.6.2 Europe In-vitro Diagnostic Services Market Size (2018-2029)
1.6.3 Asia-Pacific In-vitro Diagnostic Services Market Size (2018-2029)
1.6.4 Latin America In-vitro Diagnostic Services Market Size (2018-2029)
1.6.5 Middle East & Africa In-vitro Diagnostic Services Market Size (2018-2029)
2 In-vitro Diagnostic Services Market by Type
2.1 Introduction
2.1.1 Infectious Testing
2.1.2 Diabetes Testing
2.1.3 Molecular Testing
2.1.4 Tissue Testing
2.2 Global In-vitro Diagnostic Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2018-2023)
2.2.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In-vitro Diagnostic Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In-vitro Diagnostic Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In-vitro Diagnostic Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In-vitro Diagnostic Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In-vitro Diagnostic Services Revenue Breakdown by Type (2018-2029)
3 In-vitro Diagnostic Services Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Point-Of-Care Testing
3.1.3 Laboratories
3.1.4 Academic Institutes
3.2 Global In-vitro Diagnostic Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2018-2023)
3.2.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In-vitro Diagnostic Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In-vitro Diagnostic Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In-vitro Diagnostic Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In-vitro Diagnostic Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In-vitro Diagnostic Services Revenue Breakdown by Application (2018-2029)
4 In-vitro Diagnostic Services Competition Analysis by Players
4.1 Global In-vitro Diagnostic Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2022)
4.3 Date of Key Players Enter into In-vitro Diagnostic Services Market
4.4 Global Top Players In-vitro Diagnostic Services Headquarters and Area Served
4.5 Key Players In-vitro Diagnostic Services Product Solution and Service
4.6 Competitive Status
4.6.1 In-vitro Diagnostic Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioRad
5.1.1 BioRad Profile
5.1.2 BioRad Main Business
5.1.3 BioRad In-vitro Diagnostic Services Products, Services and Solutions
5.1.4 BioRad In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.1.5 BioRad Recent Developments
5.2 DexCom
5.2.1 DexCom Profile
5.2.2 DexCom Main Business
5.2.3 DexCom In-vitro Diagnostic Services Products, Services and Solutions
5.2.4 DexCom In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.2.5 DexCom Recent Developments
5.3 Nova Biomedical
5.3.1 Nova Biomedical Profile
5.3.2 Nova Biomedical Main Business
5.3.3 Nova Biomedical In-vitro Diagnostic Services Products, Services and Solutions
5.3.4 Nova Biomedical In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.3.5 OraSure Recent Developments
5.4 OraSure
5.4.1 OraSure Profile
5.4.2 OraSure Main Business
5.4.3 OraSure In-vitro Diagnostic Services Products, Services and Solutions
5.4.4 OraSure In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.4.5 OraSure Recent Developments
5.5 Pearl Pathways
5.5.1 Pearl Pathways Profile
5.5.2 Pearl Pathways Main Business
5.5.3 Pearl Pathways In-vitro Diagnostic Services Products, Services and Solutions
5.5.4 Pearl Pathways In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.5.5 Pearl Pathways Recent Developments
5.6 Phenomenex
5.6.1 Phenomenex Profile
5.6.2 Phenomenex Main Business
5.6.3 Phenomenex In-vitro Diagnostic Services Products, Services and Solutions
5.6.4 Phenomenex In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.6.5 Phenomenex Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen In-vitro Diagnostic Services Products, Services and Solutions
5.7.4 Qiagen In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
5.8 Roche Diagnostics
5.8.1 Roche Diagnostics Profile
5.8.2 Roche Diagnostics Main Business
5.8.3 Roche Diagnostics In-vitro Diagnostic Services Products, Services and Solutions
5.8.4 Roche Diagnostics In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Diagnostics Recent Developments
5.9 Siemens
5.9.1 Siemens Profile
5.9.2 Siemens Main Business
5.9.3 Siemens In-vitro Diagnostic Services Products, Services and Solutions
5.9.4 Siemens In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.9.5 Siemens Recent Developments
5.10 Sysmex
5.10.1 Sysmex Profile
5.10.2 Sysmex Main Business
5.10.3 Sysmex In-vitro Diagnostic Services Products, Services and Solutions
5.10.4 Sysmex In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.10.5 Sysmex Recent Developments
5.11 Thermofisher
5.11.1 Thermofisher Profile
5.11.2 Thermofisher Main Business
5.11.3 Thermofisher In-vitro Diagnostic Services Products, Services and Solutions
5.11.4 Thermofisher In-vitro Diagnostic Services Revenue (US$ Million) & (2018-2023)
5.11.5 Thermofisher Recent Developments
6 North America
6.1 North America In-vitro Diagnostic Services Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe In-vitro Diagnostic Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In-vitro Diagnostic Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In-vitro Diagnostic Services Market Dynamics
11.1 In-vitro Diagnostic Services Industry Trends
11.2 In-vitro Diagnostic Services Market Drivers
11.3 In-vitro Diagnostic Services Market Challenges
11.4 In-vitro Diagnostic Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
